Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3361 Target Snapshot

D(4) dopamine receptor · SINGLE PROTEIN · Rattus norvegicus

188Compounds
41Assays
7Approved Drugs
246.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P30729. Use UniProt P30729 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30729 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats D(4) dopamine receptor as ChEMBL target CHEMBL3361, mapped to UniProt P30729. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
D(4) dopamine receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3361
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P30729
D(4) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether D(4) dopamine receptor is the right protein anchor across sources, using UniProt P30729 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(4) dopamine receptor
UniProt AccessionP30729
Component TypeProtein
Sequence Length387 aa

D(4) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as D(4) dopamine receptor, mapped to UniProt P30729. Sequence length is 387 aa.

Mapped IDP30729
Review nameD(4) dopamine receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

7
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC501.0
KI228.0
EC5017.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1270323 9.47 Ki 0.34 Preclinical
CHEMBL267014 9.37 Ki 0.43 Preclinical
CHEMBL2037521 9.1 Ki 0.8 Preclinical
CHEMBL1270423 9.03 Ki 0.93 Preclinical
CHEMBL3289646 8.96 Ki 1.096 Preclinical
CHEMBL71724 8.85 Ki 1.4 Preclinical
CHEMBL435949 8.85 Ki 1.4 Preclinical
CHEMBL53 8.82 EC50 1.5 Approved
CHEMBL1940402 8.82 Ki 1.5 Preclinical
CHEMBL1270121 8.82 Ki 1.52 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
11
5.5
24
6.0
45
6.5
38
7.0
32
7.5
46
8.0
26
8.5
5
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ARIPIPRAZOLE
CHEMBL1112
Approved 2002
APOMORPHINE
CHEMBL53
Approved 2001
OLANZAPINE
CHEMBL715
Approved 1996
CLOZAPINE
CHEMBL42
Approved 1989
DOPAMINE
CHEMBL59
Approved 1974
HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

41
Total Assays
160
Tested Compounds
2
Assay Types
Binding — 36 assays, 160 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 16 107 7.5
cell-based format 10 41 7.5
assay format 5 1 8.6
tissue-based format 4 0
cell membrane format 1 11 6.3
Functional — 5 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 7 7.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine